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Abstract. The gold standard with regards to skin
transplantation is the use of the patient’s own skin ob-
tained from a healthy donor site. Such grafts can be
either full thickness skin or more commonly nowadays,
split thickness skin. Various materials, having either
natural and or synthetic origins, have been used in the
engineering of skin substitutes to-date and these grafts
are then confronted against autologous skin grafts. If
proven to be successful, such matrices could be utilised
in clinical applications such as in the treatment of burn
wounds and in cases of skin ulcers amongst others.
In this study the primary cells used, keratinocytes and
fibroblast, were obtained from donor skin and cultured.
Scaffolds of xenogenic (raw silk) as well as of allogenic
(acellular dermal matrices) origins were obtained via
low-cost methods and seeded using the fibroblasts and
keratinocytes so as to determine which gave the closest
mimic to skin grafts.
Out of the matrices assessed, the raw silk matrix al-
lowed the best colonisation with skin cells in our hands.
The ADM matrice also showed some cell colonisation,
but will need further experimentation.
Keywords Skin graft, silk and acellular dermal matrix
(ADM).
1 Introduction
The skin is the largest single organ of the human body.
It is composed of the epidermis, which is an epithe-
lial layer of ectodermal origin, and the dermis, a layer
of connective tissue, originated from the mesoderm.
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The epidermis consists of a stratified squamous kera-
tinized epithelium, as well as less abundant cells types
namely; melanocytes, Langerhans cells, and Merkel’s
cells. The keratinising epidermal cells are called ker-
atinocytes. Amongst many of its complex roles, one of
its major functions is to protect the body against envi-
ronmental influences. Acute or chronic loss of this bar-
rier necessitates the mechanisms of tissue repair for any
organism to survive. The most important step of such
a mechanism in the re-epithelialization of the wounded
surface is the primary destination of skin wound healing
(Slavin, 1996).
It was Revendin who introduced skin grafts for the
first time in 1871. Transplantation of the patient’s own
skin from a healthy donor site, either as a full thickness
or as a split thickness skin graft, is commonly practised
nowadays and is regarded as the surgical ”gold stan-
dard” to cover skin wounds. This is the reason every
tissue engineered skin substitute is always confronted
against the performance of autologous skin grafts.
Knowing that extensive wounds necessitate a barrier
protection to prevent both infection and desiccation, as
well as the need of cell guidance by dermal elements to
maximize healing, has led to the evolution of both bio-
logic and synthetic dressings and skin substitutes (Horch
et al., 2001). In cases of substantial burns, the great
extent of wound surfaces and considerable loss of skin
necessitated the invention of various types of temporary
or permanent skin substitutes. The clinical utility of
cultured skin substitutes for wound closure has reduced
the amount of donor skin required by at least 10 times
when compared with conventional skin grafts, and has
also reduced the number of surgeries required to harvest
donor skin, while at the same time decreasing the time
of recovery of those patients with severe burn injuries.
Theoretically, skin substitutes can be permanent or
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temporary; epidermal, dermal or composite; and bi-
ologic or alloplastic (synthetic). Biologic components
are further subdivided into autogenous, allogenic, or
xenogenic. Logically, research efforts of different groups
are centred on several possible combinations of these
traits, whereas practically, most designs rely on a per-
manent or temporary engraftment of the material. Re-
searchers in this field have defined the common tech-
niques according to their principal biological action in
the patient (Horch et al., 2005):
• Temporary – in this case the material is designed
to be placed on a fresh wound (partial thickness)
and left until healed.
• Semi-permanent – here the material remains at-
tached to the excised wound, and eventually re-
placed by autogeneous skin grafts.
• Permanent – in this type there is an incorporation
of an epidermal analogue, dermal analogue, or both
as a permanent replacement.
The increasing emphasis on rehabilitation and “qual-
ity of skin cover” has further valued this field. A skin
substitute which has the properties of a dermis is the
marker for gauging a permanent substitute. Allogenic
or alloplastic skin substitute coverage as a temporary so-
lution is necessary until definitive cover can be achieved
(Gallico, 1990). Allogenic skin grafts may be completely
integrated into the healing wound initially and bridge
the critical time gap in the early phase of burn treat-
ment, but over time they will irrevocably undergo im-
munogenic rejection (Zhao, 1992). In theory, the appli-
cation of in vitro cultivated autologous skin substitutes
is able to overcome this specific deficit of modern burn
treatment and reconstructive surgery.
Numerous studies have been conducted to date with
the aim of solving important hurdles in skin transplan-
tation. Such a problem is posed by the need for large
amounts of skin in cases of burns and chronic skin ul-
cers, with scarce donor sites. In certain trials, cells
were cultured in vitro, where the use of both autolo-
gous (Terskikh and Vasiliev, 1998) and non-autologous
(Bolivar-Flores and Kuri-Harcuch, 1999) cells were as-
sayed. Also, the use of dermal substitutes or their equiv-
alents containing bio-degradable bovine collagen, in as-
sociation with autologous cells cultured in vitro, has
been studied by Jansson and colleagues in 2001.
The matrices looked at in this study, were composed
of the following;
1.1 Protein Matrices
In general, around 60 percent of the polypeptide chain
exists as two regular secondary structures, namely a he-
lices and the B-sheets. The remainder of the molecule
is in random turns and coils. Thus these helices and
sheets are the major internal supportive elements of the
protein itself.
Proteins having structural roles in cells, and thus hav-
ing to span over a large distance, generally have an elon-
gated three dimensional structure and are commonly re-
ferred to as fibrous proteins.
1.1.1 Silk
Silk derived from the silkworm, Bombyx mori, has been
utilised as a biomedical material for applications such
as sutures for many decades. According to (Altman
et al., 2003), silk has distinctive mechanical character-
istics that may be utilised in the field of clinical repair
options with many possible applications. Although bio-
incompatibility of these fibres has been the major draw
back in their utilisation; it has been demonstrated that
this was most likely due to some residual proteins which
may have contaminated the silk, not to the nature of
the fibres themselves.
Many structural proteins are composed of multiple
layers of pleated sheets that provide toughness. Silk
fibres consist mostly of stacks of antiparallel B-sheets.
The fibres are flexible because these B-sheets can slip
over one another. Also, their resistance to breakage is
derived from the fact that the silk’s peptide backbone
is aligned with the fibre’s axis. In fact, core silk fibroin
has been shown to exhibit biocompatibility both in vivo
and in vitro comparable with that of other widely used
biomaterials such as collagen and polylactic acid (Alt-
man et al., 2003). Also, this study underlines the fact
that silk fibres posses numerous different side chains to
which growth factors, as well as adhesion factors, could
be added. Another advantage of silk fibres is that these
may be genetically tailored, making silk even more vi-
able for biomedical utilisation which is in fact what is
presently ongoing.
The use of spider silk has also been intensively as-
sessed by (Yager, 1997), amongst many others, in order
to determine its structure and physical as well as chem-
ical properties so that such silk could also be used as an
application in the future as a matrix for tissue engineer-
ing.
Genetic engineering techniques have been utilised in
the synthesis of recombinant spider silk fibroin-mimetic
polymers that have been proven to possess excellent me-
chanical properties (Guerette et al., 1996), as well as an
improved cell adhesion capacity, as shown by (Bini et al.,
2006).
Applications of silk include being scaffolds for tissue
engineering, especially after the recent results obtained
in trying to produce both ligament and bone formation
in vitro. (Altman et al., 2003) thus conclude that such
studies support the great potential of silk as a biomate-
rial for future clinical applications. Other studies have
underlined the fact that silk is very versatile with re-
spect to biocompatabilty, biodegradation, controllable
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degradation rates (Rice et al., 2005; Urist, 1965) and
the potential of being turned into a number of differ-
ent formats including gels, porous structures and fibres
(Preda et al., 2013).
1.2 Acellular Dermal Matrix (ADM)
There have been many attempts to produce a dermal
substitute. The most successful of these substitutes
seem to be ones derived from either full or split thickness
skin treated to remove all epidermal and dermal cellu-
lar components and appendages such as keratinocytes,
fibroblasts, hair, sweat glands and smooth muscle (Wal-
ter et al., 1998).
This substitute should exhibit three very important
properties namely; low antigenicity, the ability to vas-
cularise rapidly and to be stable as a dermal template.
2 Methods used
2.1 Isolation of Fibroblasts and Ker-
atinocytes
The skin (full thickness skin) was collected through
informed consent of the patients during surgeries such
as circumcisions, tummy tucks and facelifts. The skin
was then cleaned and collected into 50ml tubes that
had been filled prior to this with RPMI 1640 (10%
FBS, 100μg/ml of streptomycin, 100U/ml of penicillin,
2.5μg/ml amphoteracin B) and stored at 4◦C. These
samples were processed within 36 hours under clean con-
ditions. The method used was adopted from an estab-
lished protocol by (Jones et al., 1996) and separation of
epidermis and dermis was achieved overnight by dispase
digestion at 4◦C. The epidermis was cultured in Ker-
atinocyte Growth Medium (KGM) (100μg/ml of strep-
tomycin, 100U/ml of penicillin, 2.5μg/ml amphoteracin
B) to obtain keratinocytes. The dermis was cultured
in DMEM F12 (10%FBS, 100μg/ml of streptomycin,
100U/ml of penicillin) to obtain fibroblasts.
2.2 Silk
The silk matrices were made from layers of raw silk
peeled off the cocoon of the mulberry moth Bombyx
mori (with the aid of a scalpel blade no.24). These layers
were cut into small pieces (5mm by 5mm), then wrapped
in foil and autoclaved.
2.3 Acellular Dermal Matrices
First the epidermal layer of formalin-fixed cadaveric
skin was scraped off using a scalpel. A modified version
of the method described by (Walter et al., 1998) was
then followed. Briefly, the skin was incubated overnight
in 1M NaCl at 37◦C with continuous agitation. Next
the skin was placed in 0.5% sodium dodeycl sulphate
(SDS) solution for 1 hour at room temperature, again
with continuous shaking. Both solutions used contained
0.02% sodium azide so as to prevent microbiological
growth. The acellular dermal matrices were then ex-
tensively washed using sterile PBS and were then trans-
ferred using sterile forceps into cryovials. Then, 1ml of
sterile PBS was added and the sample was frozen at
−20◦C.
2.4 Seeding of the Matrices
The matrices were seeded, under sterile conditions, us-
ing a fibroblast suspension of around 1.5× 106 cells/ml.
Two weeks following the seeding of the silk matrix with
fibroblast, the matrices were seeded with keratinocytes.
In the case of the ADM, seeding with keratinocytes was
undergone after four weeks. At this stage, a suspension
of keratinocytes at a concentration of 1x106 cells/ml was
used. The matrices were kept under microscopic obser-
vation for the following weeks.
Figure 1: Cells attached all round silk fibres. (Magnification
×200).
Figure 2: Spaces between silk fibres are bridged with cells. (Mag-
nification ×400).
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3 Results
3.1 Silk Matrix
Cells were seen to attach very rapidly into the silk fibres
(Figure 1). At week six, that is, 30 days after the seeding
of keratinocytes, cells were seen to spread out onto the
silk fibres. Extended bridging between a relatively wide
area of silk fibre was also observed (Figure 2).
Figure 3: Cells attached onto the ADM’s collagen strands. (Mag-
nification ×400).
3.2 Acellular Dermal Matrix
Cells were seen to grow compactly and uniformly onto
collagen strands that spread out from the matrix’s mar-
gins (Figure 3).
Next, the ADMs were stained with a Haematoxylin
and Eosin (H&E) stain so as to investigate to what ex-
tent the fibroblasts and keratinocytes seeded attached
onto the outer layer of the ADMs and whether the cells
migrated deep into the inner layers of this collagen ma-
trix.
4 Discussion
4.1 The Silk Matrix
The cells attached to the silk fibres relatively quickly
when compared to the acellular dermal matrix. Also,
over time the clusters of cells were seen to grow along
the silk fibrils with frequent bridging between two or
more of these structures. The cells were in fact seen to
bridge even between not-so-close fibrils, over a period
of four weeks, cells were seen to bridge over a relatively
large span between multiple silk fibres, which was not
seen in hair matrix cultures. Thus, silk seems to be
relatively better in acting as a matrix onto which large
films of cells form.
4.2 Formalin fixed Acellular Dermal
Matrix
Unlike in the case of (Walter et al., 1998), who used
fresh skin (stored at −20◦C and thawed before the de-
cellularisation process), formalin-fixed skin was used in
this study since this was freely available in the depart-
ment. Another study conducted by (Gibbs et al., 2006)
prepared ADMs from glycerol-preserved door skin, thus
formalin preserved ADMs might have been viable to
achieve.
Our experience showed that both the decellularisa-
tion process, as well as the successive cell-seeding, were
markedly less efficient with formalin-fixed skin and that
this resource may need some treatment to reverse the
effects of formalin (similar to the microwave antigen re-
trieval process for immunocytochemistry) to be a suit-
able source. Non-fixed skin (possibly derived from cos-
metic procedures) is obviously a resource which should
be investigated further.
With regard to cost effectiveness, although the acel-
lular dermal matrices were cost-free to obtain, the
reagents needed to process the matrices were both costly
as well as relatively hazardous. While in the case of the
silk, the cocoons were obtained at a very low cost and
processing was practically cost-free. These facts helped
make silk an ideal candidate for studies involving its util-
isation as a matrix onto which skin grafts are moulded.
Another point in this matrix’s favour is the fact that
core silk fibroin has been shown to exhibit biocompat-
ibility both in vivo and in vitro, comparable with that
of other widely used biomaterials such as collagen and
polylactic acid (Altman et al., 2003). Combination ma-
trices made from processed skin dermis, together with a
silk framework or other related structure, may be future
avenues to explore.
5 Conclusions
In the case of the acellular dermal matrix, being de-
rived from formalin-fixed cadaveric skin, the formalin
may have altered the protein surfaces rendering the ad-
hesion of cells more difficult with respect to other ma-
trices investigated.
The silk matrix seemed to be a good candidate for
the development of skin structures, although studies
have outlined the fact that raw silkworm silk can be im-
munogenic due to the protein sericin and that a degum-
ming process should be carried out first (Kearns et al.,
2008). Unfortunately, this in turn distorts the structure
of the silk fibrons themselves and effects the mechani-
cal properties (Langer and Vacanti, 1993), while sericin
coated materials have been shown to aid cell adhesion
and growth of human fibroblasts (Vacanti, 2001).
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